Elisabetta Moratti

507 citations
15 papers · 401 indexed · h-index 11
Topics
Protein Tyrosine Phosphatases (5 papers)Chronic Myeloid Leukemia Treatments (4 papers)Complementary and Alternative Medicine Studies (3 papers)

In The Last Decade

Elisabetta Moratti

15 papers receiving 378 citations

Peers

Elisabetta Moratti
Comparison fields: 5 of 99
  • Molecular Biology 135
  • Complementary and alternative medicine 116
  • Biophysics 69
  • Physiology 51
  • Hematology 41
Replace Slavik Koval with:
Slavik Koval Netherlands
Tingting Han China
Shyam S. Agarwal India
Szymon Plewa Poland
Ronald E. J. Mitchel Canada
Yun Gao China
Veronika Vidová Czechia
Daniela D. de Carvalho Brazil
Elisabetta Moratti relative to Slavik Koval Netherlands Slavik Koval's profile →
Citations per field
00.5×7.7×
Slavik Koval · 1×
Citations per year

Countries citing papers authored by Elisabetta Moratti

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Moratti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Moratti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Moratti more than expected).

Fields of papers citing papers by Elisabetta Moratti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Moratti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Moratti. The network helps show where Elisabetta Moratti may publish in the future.

Co-authorship network of co-authors of Elisabetta Moratti

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Moratti. A scholar is included among the top collaborators of Elisabetta Moratti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Moratti. Elisabetta Moratti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 29
2 49
3 19
4 28
5 65
6 65
7 18
8 18
9 11
10 40
11 44
12 7
13
Protein tyrosine phosphatase receptor type gamma (PTPRG) is a functional tumor suppressor gene specifically down-regulated in chronic myeloid leukemia (CML)
1
14 1
15 6

About Elisabetta Moratti

Elisabetta Moratti is a scholar working on Complementary and alternative medicine, Hematology and Biophysics, having authored 15 papers that have together received 401 indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Complementary and Alternative Medicine Studies (3 papers). The work is most often cited by research in Complementary and alternative medicine (116 citations), Biophysics (69 citations) and Drug Discovery (1 citation). Elisabetta Moratti has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Paolo Bellavite, Debora Olioso, Marta Marzotto, Anita Conforti, Marzia Vezzalini, Claudio Sorio, Marco Della Peruta, Gianfelice Cinque, G. Bellisola and Luisa Tomasello. Their work appears in journals such as PLoS ONE, Cancer Research and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026